Laboratory Centrifuge Market - Forecast(2021 - 2026)

Report Code: HCR 0549 Report Format: PDF + Excel (Delivery in 48 Hrs)

Laboratory Centrifuge Market Overview

The laboratory centrifuge market is estimated to reach $1.24 billion by 2026 and is poised to grow at a CAGR of 2.3% over the forecast period of 2021-2026. A laboratory centrifuge helps in separating liquid samples at a high rate of speed. A centripetal acceleration induces the centrifuge to separate items and substances based on densities. The speed at which the motor moves of the centrifuge allows the heavier metals to fall out of the vessel. The laboratory centrifuge is excessively used for academic purposes, as it helps them follow procedures of sedimentation and separate the main constituent from the liquid. Owing to various characteristics, the centrifuge models differ and allow the user to perform various functions. For example, swinging bucket rotors feature a full path length, run slowly, and, more importantly, the tube changes its angle during the run. It is used in culture processing and harvesting cells from growth.

The rise in technological advancement, which now allows the users to perform function efficiently and at high speeds along with an increase in the prevalence of diseases such as HIV and hepatitis, and lastly in diagnosing cases of Sars-Cov-19 are some of the factors which will drive the laboratory centrifuge industry forward in the projected period of 2021-2026.

Report Coverage

The report: Laboratory Centrifuge Market Forecast (2021-2026)”, by Industry ARC covers an in-depth analysis of the following segments of the Laboratory Centrifuge Market.

By Product- Benchtop and Floor Standing.
By Rotor Design- Swinging Bucket Rotors, Fixed Angle Rotors, Vertical Rotors, and Others.
By Application- Microbiology, Diagnostics, Cellonomics, Proteomics, Genomics, and Others.
By End User- Hospitals, Biotechnology, and Pharmaceutical & Academic Research.
By Intended Use- General Purpose Centrifuge, Clinical Centrifuge, and Pre-Clinical Centrifuge.
By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (the Middle East, and Africa).

Key Takeaways

  • Geographically, North America’s laboratory centrifuge market held a dominant market share. It is owing to the allotment of funds for research and developments along with the presence of major pharmaceutical and biotechnology companies. However, Asia-Pacific is estimated to offer lucrative growth opportunities to the marketers owing to the rising allocation of government funds for research and development and due to the overall increase in the budgetary allocation for healthcare.
  • The technological advancement to develop efficient centrifuge has been the key market driver. However, the high costs associated with procuring the device will act as a grave market challenge.
  • A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the laboratory centrifuge market report.

    Laboratory Centrifuge Market Share- Geography as (%) for 2020

    Laboratory Centrifuge Market Share- Geography

For More Details on This Report - Request for Sample

Laboratory Centrifuge Market Segmentation Analysis - By Product

The laboratory centrifuge market based on the product can be further segmented into Benchtop and Floor Standing. The benchtop centrifugal segment held the dominant market share in the year 2020. It is owing to the relatively easier forms of keeping the machines, and also the machines being versatile and easy to use, and lastly lighter in weight. Moreover, ESRD cases have resulted in an increased fatality, as deaths per 1,000 cases have ramped up by 8.7-12.9. Additionally, research and development costs by companies have risen multitudes.

However, the Floor standing segment is estimated to be the fastest-growing, with a CAGR of 2.6% over the forecast period of 2021-2026. It is owing to the additional features offered, such as, it can work in temperatures between -20 C to +40 C. Additionally, they can be used across in the DNA, RNA, Viral, and protein research applications, which will be immensely supplemented from vaccine-related work. 

Laboratory Centrifuge Market Segmentation Analysis - By End User

The laboratory centrifuge market based on the end-users can be further segmented into hospitals, biotechnology, and pharmaceuticals & Academic Research. The biotechnology & Pharmaceutical’s segment held the dominant market share in the year 2020. It is owing to the COVID-19 surge and the increasing pressure on pharmaceutical and biotechnology companies to develop a vaccine or a drug to counter. Moreover, the profitability index of such companies was higher than other industries and counterparts.

Moreover, the pharmaceutical and biotechnology segment is estimated to be the fastest-growing, with a CAGR of 2.7% over the forecast period of 2021-2026. It is owing to the budgetary allocation to certain companies to develop better medications or vaccines, or drugs. For example, M-RNA vaccines are supposedly under trial for curing cancer, whereby various samples and assays are used to find the right composition. Similarly, other competitors are advancing to tackle the competition, which is further allowing the market to grow.

Laboratory Centrifuge Market Segmentation Analysis - By Geography

The laboratory centrifuge market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held a dominant share of 38% as compared to the other regions in the year 2020. It is owing to the predominant manufacturers pertaining to drugs and vaccines physically situated in the following region. Moreover, the government of the following region spends excessively, as, in 2020, the U.S government allocated $2 billion to Pfizer for developing the coronavirus vaccine.

However, Asia-Pacific is set to offer lucrative growth opportunities to marketers. It is owing to the rising cardiovascular ailments across the regions, particularly in low-income countries. As 77% of the deaths due to NCDs are caused in low-income countries, hence active government participation and budgetary allocation allow the market to grow at a steadfast pace.

Laboratory Centrifuge Market Drivers

An increase in R&D expenditures will aid the growth of the laboratory centrifuge market

The proportion of budget which goes forward for the development of improved and efficient technology has been increasing. Moreover, pharmaceutical and biotechnology companies rank 1st in terms of spending on such costs. For example, $190.9 billion were spent by pharma and biotech companies in 2018, which ultimately helped them realize a net revenue of $ 1251 billion. The increase in the costs by private companies and government alike to counter the geriatric uprising population. As per US CDC experts, by 2030, 1 in every 5 Americans will be above the age of 65+. Further, the geriatric population is prone to diseases more than their counterpart.

An increase in the cases of non-communicable diseases has acted as a driver for the following market

Laboratory centrifuges are the basis for performing the majority of blood tests. Moreover, as per WHO, 41 million people each year die due to NCDs; further, WHO has provided screening as a quintessential step to counter the rising cases of such diseases. As 77% of the deaths owing to NCDs take place in the low- and middle-income countries, efforts are globally made to increase the testing facilities. The strategy to get hold of the disease at the benign stage has been the key objective of the entire process, which has aided the growth of centrifugal devices. Additionally, countries like India allotted INR 4062 crores in 2020-2021 for healthcare research expenditure out of the total budgetary allocation.

Laboratory Centrifuge Market Challenges

Attribution to the release of harmful aerosols along with high device costs is set to hamper the growth of the market

According to the University of Minnesota, 80% of the infections which are communicable in nature are spread with the release of harmful aerosols. Owing to high centripetal acceleration and in-efficient tubes the aerosols are released, and the lab technician working, latches on to such pathogens. Interestingly, Sar-Cov-19 has also been attributed as an accident of “lab-leak.” Companies are spending an extra portion of their budgets to maintain the overall safety of the facility. Lastly, centrifugal devices can cost more than $6000 on average, additionally, more facilities and advancement attract higher prices. The following can be thought of as the major market challenge. 

Laboratory Centrifuge Market Competitive Landscape

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the laboratory centrifuge market. The top 10 laboratory centrifuge market companies include:

  1. Thermo Fisher Scientific Inc.
  2. Danaher Corporation
  3. Eppendorf AG
  4. Sigma Laborzentrifugen GmbH
  5. Andreas Hettich GmbH & Co. KG
  6. Kubota Corporation 
  7. Koki Holdings Co., Ltd. (Japan) (previously Hitachi Koki Co., Ltd.),
  8. QIAGEN N.V.
  9. NuAire (US), Sartorius
  10. Becton, Dickinson, and Company 

Recent Developments

  • In June 2021, MagFuge from Health Care Logistics is a combination high-speed centrifuge and magnetic stirrer with a compact, low-profile design for use in labs with height restrictions or limited space. Multiple stirring modes are possible and both speed and time are adjustable. MagFuge is complete with two silicone mats to help prevent spills and keep the unit stable. Lastly, it is also available in a refrigerated version.
  • In May 2021, Helmer Scientific launched Hettich Mikro 200 Centrifuge. It offers quality and is designed to offer various speeds. Moreover, it contains multiple rotors and accessories Additionally, it has the capability to remove lipemia in serum and plasma samples with time no more than 15 minutes. Further, it has the capacity to hold 30 x 1.5/2 ML with a maximum speed of 15000 RPM or 21832 RCF. Lastly, it is available in a refrigerated version. 

Relevant Titles

Report Code- AIR 0302

Report Code- ESR 0125

For more Lifesciences and Healthcare related reports, please click here

1. Laboratory Centrifuge Market- Overview
    1.1 Definitions and Scope
2. Laboratory Centrifuge Market- Executive Summary
    2.1 Market Revenue, Market Size, and Key Trends
    2.2 Key trends by Product 
    2.3 Key trends by Rotor Design
    2.4 Key trends by Geography
3. Laboratory Centrifuge Market- Comparative Analysis
    3.1 Company Benchmarking – Key Companies
    3.2 Financial Analysis– Key Companies
    3.3 Market Share Analysis– Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis- Average Selling Price
4. Laboratory Centrifuge Market- Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Laboratory Centrifuge Market– Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Case Studies of Successful Ventures
6. Laboratory Centrifuge Market- Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Laboratory Centrifuge Market– Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Laboratory Centrifuge Market– By Product (Market Size –$Million/$Billion)
    8.1 Benchtop
    8.2 Floor Standing
9. Laboratory Centrifuge Market– By Rotor Design (Market Size –$Million/$Billion)
    9.1 Bucket Rotors
    9.2 Fixed Angle Rotors
    9.3 Vertical Rotors
    9.4 Others
10. Laboratory Centrifuge Market– By Application (Market Size –$Million/$Billion)
    10.1 Microbiology
    10.2 Diagnostics
    10.3 Cellonomics
    10.4 Proteomics
    10.5 Genomics
    10.6 Blood Component Separation
    10.7 Others
11. Laboratory Centrifuge Market– By End User (Market Size –$Million/$Billion)
    11.1 Hospitals
    11.2 Biotechnology & Pharmaceutical
    11.3 Academia and Research
12. Laboratory Centrifuge Market– By Intended Use (Market Size –$Million/$Billion)
    12.1 General Purpose Centrifuge
    12.2 Clinical Centrifuge
    12.3 Preclinical Centrifuge
13. Laboratory Centrifuge Market- By Geography (Market Size –$Million/$Billion)
    13.1 North America
        13.1.1 U.S.
        13.1.2 Canada
        13.1.3 Mexico
    13.2 Europe
        13.2.1 U.K.
        13.2.2 Germany
        13.2.3 France
        13.2.4 Italy
        13.2.5 Spain
        13.2.6 Russia
        13.2.7 Rest of Europe
    13.3 Asia-Pacific
        13.3.1 China
        13.3.2 India
        13.3.3 Japan
        13.3.4 South Korea
        13.3.5 Australia & New Zealand
        13.3.6 Rest of Asia-Pacific
    13.4 South America
        13.4.1 Brazil
        13.4.2 Argentina
        13.4.3 Rest of South America
    13.5 Rest of the World
        13.5.1 Middle East
        13.5.2 Africa
14. Laboratory Centrifuge Market- Entropy
15. Laboratory Centrifuge Market– Industry/Segment Competition Landscape Premium 
    15.1 Market Share Analysis
        15.1.1 Global Market Share – Key Companies
        15.1.2 Market Share by Region – Key companies
        15.1.3 Market Share by Countries – Key Companies
        15.1.4 Competition Matrix
        15.1.5 Best Practices for Companies
16. Laboratory Centrifuge Market– Key Company List by Country Premium Premium
17. Laboratory Centrifuge Market Company Analysis
    17.1 Company 1
    17.2 Company 2
    17.3 Company 3
    17.4 Company 4
    17.5 Company 5
    17.6 Company 6
    17.7 Company 7
    17.8 Company 8
    17.9 Company 9
    17.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.